Show simple item record

dc.contributor.authorConstantinou, Constantinaen
dc.contributor.authorNeophytou, Christiana M.en
dc.contributor.authorVraka, Panayiota S.en
dc.contributor.authorHyatt, John Anthonyen
dc.contributor.authorPapas, Konstantinos A.en
dc.contributor.authorConstantinou, Andreas I.en
dc.creatorConstantinou, Constantinaen
dc.creatorNeophytou, Christiana M.en
dc.creatorVraka, Panayiota S.en
dc.creatorHyatt, John Anthonyen
dc.creatorPapas, Konstantinos A.en
dc.creatorConstantinou, Andreas I.en
dc.date.accessioned2019-11-04T12:50:24Z
dc.date.available2019-11-04T12:50:24Z
dc.date.issued2012
dc.identifier.urihttp://gnosis.library.ucy.ac.cy/handle/7/53010
dc.description.abstractVitamin E comprises 8 functionally unique isoforms and may be a suitable candidate for the adjuvant treatment of prostate cancer. In this study, we examined the ability of 2 vitamin E isoforms [α-tocotrienol (γ-TT) and δ-tocotrienol (δ-TT)] and 4 synthetic derivatives [γ- and δ-tocotrienol succinate (γ-TS, δ-TS), α-tocopheryl polyethylene glycol succinate (TPGS), and -tocopheryl polyethylene glycol ether (TPGS-e)] of vitamin E to induce cell death in AR (DU145 and PC-3) and AR+ (LNCaP) prostate cancer cell lines. Our results show that δ-TT and TPGS-e are the most effective isoform and synthetic derivative, respectively, of all compounds examined. Overall, the results of our study suggest that isoforms and synthetic derivatives of vitamin E have the potency to trigger both caspase-dependent and -independent DNA damage and dominant caspase-independent programmed cell death. The capacity of vitamin E to trigger caspase-independent programmed cell death suggests that it may be useful in the chemotherapy of prostate cancer since it may prevent the tumor resistance commonly associated with the use of classical chemotherapeutic agents that trigger caspase-dependent programmed cell death. © 2012 Copyright Taylor and Francis Group, LLC.en
dc.sourceNutrition and canceren
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84856845784&doi=10.1080%2f01635581.2012.630167&partnerID=40&md5=cec01e4681feb77cec88a4e52b025b87
dc.subjectarticleen
dc.subjectMaleen
dc.subjectantineoplastic agenten
dc.subjectetoposideen
dc.subjecthumanen
dc.subjectHumansen
dc.subjectcontrolled studyen
dc.subjectunclassified drugen
dc.subjectprostate canceren
dc.subjectPolyethylene Glycolsen
dc.subjecthuman cellen
dc.subjectapoptosisen
dc.subjectenzyme activityen
dc.subjectProstatic Neoplasmsen
dc.subjectcancer cell cultureen
dc.subjectCaspasesen
dc.subjectDNA damageen
dc.subjectcaspase 3en
dc.subjectCell Line, Tumoren
dc.subjectDrug Screening Assays, Antitumoren
dc.subjectalpha tocopherolen
dc.subjectVitamin Een
dc.subjectalpha tocopheryl polyethylene glycol etheren
dc.subjectalpha tocopheryl polyethylene glycol succinateen
dc.subjectcarbobenzoxy valylalanylaspartyl(o methyl)fluoromethyl ketoneen
dc.subjectcaspase inhibitoren
dc.subjectdelta tocotrienolen
dc.subjectdelta tocotrienol succinateen
dc.subjectgamma tocotrienolen
dc.subjectgamma tocotrienol succinateen
dc.subjectIsomerismen
dc.subjectPoly(ADP-ribose) Polymerasesen
dc.titleInduction of DNA damage and caspase-independent programmed cell death by vitamin een
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1080/01635581.2012.630167
dc.description.volume64
dc.description.startingpage136
dc.description.endingpage152
dc.author.facultyΣχολή Θετικών και Εφαρμοσμένων Επιστημών / Faculty of Pure and Applied Sciences
dc.author.departmentΤμήμα Βιολογικών Επιστημών / Department of Biological Sciences
dc.type.uhtypeArticleen
dc.description.notes<p>Cited By :18</p>en
dc.source.abbreviationNutr.Canceren
dc.contributor.orcidConstantinou, Andreas I. [0000-0003-0365-1821]
dc.gnosis.orcid0000-0003-0365-1821


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record